SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor

Medicine & Life Sciences

• N-(5-(((5-(1,1-dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide 100%
• Vascular Endothelial Growth Factor A 43%
• Human Umbilical Vein Endothelial Cells 26%
• Capillaries 24%
• Neoplasms 16%
• Endothelial Cells 13%
• Coculture Techniques 12%
• Cyclin-Dependent Kinase 9 10%
• Cyclin-Dependent Kinase 2 8%
• Cell Proliferation 8%
• Cell Line 7%
• Glioblastoma 6%
• In Vitro Techniques 5%
• Cell Movement 5%
• Cell Cycle 4%
• Blood Vessels 3%